Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-04-014737
Filing Date
2004-12-14
Accepted
2004-12-13 21:49:49
Documents
8
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 10-K y69543e10vk.txt 10-K 480923
2 AMENDED AND RESTATED STOCK INCENTIVE AGREEMENT y69543exv10w10.txt EX-10.10 37143
3 SUBSIDIARIES y69543exv21.txt EX-21 305
4 CONSENT OF KPMG LLP y69543exv23.txt EX-23 1767
5 CERTIFICATION y69543exv31w1.txt EX-31.1 3582
6 CERTIFICATION y69543exv31w2.txt EX-31.2 3657
7 CERTIFICATION y69543exv32w1.txt EX-32.1 1493
8 CERTIFICATION y69543exv32w2.txt EX-32.2 1525
  Complete submission text file 0000950123-04-014737.txt   532908
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 041200121
SIC: 2835 In Vitro & In Vivo Diagnostic Substances